ArticleCureus2025
Predictive Value of C-Reactive Protein/Albumin Ratio in Acute Pancreatitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dynamic Assessment of the C-Reactive Protein-to-Albumin Ratio Improves Early Prediction of Severe Acute Pancreatitis: A Retrospective Cohort Study.Life (Basel, Switzerland) · 2026Article
- Comparative analysis of four nutritional scores in predicting hospital stay duration for EICU Patients with acute pancreatitis.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Acute pancreatitis (AP) is a common and potentially life-threatening condition with a wide spectrum of severity. While most cases are mild, a subset progresses to severe disease with high mortality. This study evaluates the predictive value of the C-reactive protein (CRP)/albumin ratio (CAR), an inflammation-based biomarker, in determining AP severity. Methods A prospective, observational study was conducted among adult patients diagnosed with AP. CRP and albumin levels were measured at presentation, and CAR was calculated and categorized into three quantiles (≤6.7, 6.7-30.5, ≥30.5). Associations between CAR quantiles and disease severity were analyzed using Fisher's exact test. Pearson correlation assessed the relationship between CAR and hospital stay. Receiver operating characteristic (ROC) analysis was performed to evaluate diagnostic performance, with optimal cutoffs determined by Youden's index. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated at both the Youden cutoff and a lower pragmatic threshold. Results Among the 80 participants (55% male; median age 44.5 years), the median CAR was 12.7. No patients in the lowest CAR quantile developed severe AP. CAR demonstrated good discriminatory ability for severe AP (AUC 0.862). The optimal Youden cutoff of 18.39 yielded 100% sensitivity and 69.4% specificity. At a lower cutoff of 10.28, sensitivity remained 100%, while specificity decreased to 40.3%. CAR values were positively correlated with hospital stay duration (r = 0.568, p < 0.001). Conclusion CAR is a simple, inexpensive, and non-invasive marker that predicts AP severity. Low CAR values are associated with a reduced risk of severe AP. Using CAR, particularly at a lower threshold, may help identify high-risk patients early and guide management decisions in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.